Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1104 of 6351
-
New stem cell approach aims to cure rare immune disease
Disease control OngoingChronic granulomatous disease (CGD) affects white blood cell function. Currently, the only curative treatment is bone marrow transplant to replace the abnormal stem cells with new ones (donor cells) capable of making a normal immune system. Transplant problems include graft versu…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a gene test spare some breast cancer patients from radiation?
Knowledge-focused OngoingThis research study is a way of gaining new knowledge about whether patients can omit radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify which patients may not need radiation.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control OngoingThis phase I trial studies the side effects and the best dose of genetically modified T-cells after lymphodepleting chemotherapy in treating patients with acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm that has returned after a period of improvement or has…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New IV drug shows promise for severe Post-Birth depression
Symptom relief CompletedThis is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:10 UTC
-
New radiation approach targets tough pancreatic tumors
Disease control CompletedThis research study is for people who have pancreas cancer for which surgery is not recommended. Potential patients must have already received several months of chemotherapy before they are eligible for this study and there will not have been any detectable spread of their tumor …
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Beetroot juice may boost heart blood flow and walking in leg artery disease
Disease control CompletedIn this study the investigators will test the hypothesis that short-term consumption of inorganic nitrate (supplied in concentrated beetroot juice) enhances coronary blood flow responses, large artery hemodynamics, and leg oxygenation/exercise tolerance in patients with periphera…
Phase 2 • Sponsor: David N. Proctor, PhD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Triple-Drug attack shows promise against multiple myeloma
Disease control CompletedThis research study is evaluating a combination of three drugs called lenalidomide, subcutaneous (injection under the skin) bortezomib, and dexamethasone (RVD) as a possible treatment for multiple myeloma.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to cut treatment breaks for anal cancer patients
Disease control CompletedAnal canal carcinoma (ACC) represents 1.2% of digestive cancers. Its incidence is increasing. As epidermoid ACC (95% of ACC) are particularly sensitive to radio and chemotherapy, concomitant radio-chemotherapy is the standard treatment of locally advanced ACC, with proven efficac…
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for myeloma patients Who've run out of options?
Disease control CompletedThis study evaluates a new treatment combination of ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory multiple myeloma. Participants will either receive ixazomib with cyclophosphamide and dexamethasone or cyclophosphamide and dexamethasone alone.
Phase 2 • Sponsor: University of Leeds • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Surgery may reverse early diabetes without meds
Disease control OngoingBariatric surgery is efficient in both inducing adequate weight loss and the control of glycemia in obese patients affected by Type 2 Diabetes Mellitus (T2DM). Despite growing evidence suggesting that early performance of bariatric surgery on obese patients with T2DM offers the …
Sponsor: Azienda Ospedaliera Santa Maria, Terni, Italy • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug combo aims to slow Progeria's effects
Disease control By invitation onlyThis is a phase I/II dose-escalation trial of everolimus in combination with lonafarnib in Hutchinson-Gilford Progeria Syndrome (HGPS) and progeroid laminopathies (henceforth "progeria"). The study will be conducted at a single clinical site utilizing the Clinical and Translation…
Phase 1/2 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Milk allergy treatment shows promise in Long-Term quality of life study
Disease control CompletedThe outcomes of oral immunotherapy (OIT) in food allergy study will provide more knowledge of oral immunotherapy. So far the OIT has showed in clinical experiments to be a interesting way to increase the unresponsiveness in severe food allergies. However little is known about it´…
Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to boost survival in advanced lung cancer
Disease control CompletedTo compare the overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy with docetaxel + plinabulin (DP Arm) to patients treated with docetaxel + placebo (D5W) (D Arm) for advanced or metastatic disease. Secondary purposes of the study are: * To compare ov…
Phase 3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Immune booster vaccine shows promise against deadly brain cancer
Disease control OngoingIn this phase I/II trial, the primary objective is to determine overall and progression-free survival of patients with newly diagnosed glioblastoma when autologous Wilms' tumor 1 (WT1) messenger (m)RNA-loaded dendritic cell (DC) vaccination is added to adjuvant temozolomide maint…
Phase 1/2 • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a common diabetes drug stop breast cancer before it starts?
Prevention OngoingThis randomized phase III trial studies metformin hydrochloride to see how well it works compared to placebo in preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The us…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Gene therapy trial aims to boost HIV fight in lymphoma patients
Disease control OngoingThis pilot clinical trial studies gene therapy following combination chemotherapy in treating patients with acquired immune deficiency syndrome (AIDS)-related non-Hodgkin lymphoma. Placing genes that have been shown in the laboratory to inhibit the growth and spread of the immuno…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a donor stem cell transplant fix broken immune systems?
Disease control Recruiting nowBackground: Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers think this may help people with immune system problems. Objective: To see if allogeneic blood or bone marrow transplan…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Twin pregnancy breakthrough? study tests simple devices to stop early labor
Prevention CompletedThis protocol outlines a randomized trial of 630 women evaluating the use of micronized vaginal progesterone or pessary versus control (placebo) to prevent early preterm birth in women carrying twins and with a cervical length of less than 30 millimeters.
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Tailored radiation boosts lung cancer control in new trial
Disease control CompletedIn patients with locally advanced stage III non-small cell lung cancer, the probability of local control remains low (about 17% at 1 year). Concomitant radio-chemotherapy is the standard treatment. An increase in total radiotherapy dose (from 66 to 74 Gray) has been proposed to i…
Phase 2 • Sponsor: Centre Henri Becquerel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug combo targets Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this study is to test the safety and effectiveness of the investigational drug, palbociclib with bicalutamide for the treatment of triple negative, androgen receptor positive breast cancer.
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC